Accessible through Lexicomp Online and Lexicomp® Mobile App offerings, Lexi-Drugs will now be used by CMS and healthcare professionals as a trusted knowledge resource to help determine coverage
The products include Mucinex DM Regular Strength (guaifenesin 600mg and dextromethorphan 30mg); Mucinex DM Maximum Strength (guaifenesin 1200mg and dextromethorphan 60mg); Mucinex Maximum Strength (guaifenesin 1200mg). Perrigo will
The panel can be analyzed on the full line of nCounter Analysis Systems, including the new nCounter SPRINT™ Profiler, utilizing breakthrough technology, which simultaneously measures both RNA and
In conjunction with the agreement, the scientific team that developed DiCAST, including the lead inventor, Dr. Paul Leonard, has joined Vaccinogen and will spearhead the Company’s operations in
Alligent is a leading Medical Affairs agency that develops and delivers strategically-focused, integrated and aligned medical communications solutions to the biopharma industry. The deal was supported by the
BL-5010 is a novel product for the non-surgical removal of benign skin lesions. It offers an alternative to painful, invasive and expensive removal treatments including cryotherapy, laser treatment
Bioceros is a privately-held, Netherlands-based biopharmaceutical R&D company focused on the development of mAbs and generation of GMP-ready cell lines. Over the past decade, Bioceros has developed numerous
The partnership harnesses Certara’s unmatched biosimulation (modeling and simulation) and regulatory writing capabilities, with Paidion’s regulatory strategy and pediatric clinical trial management expertise to address the critical challenges
These technologies relate to the development of stem cells into glucose-responsive therapeutic cells for the treatment of patients with insulin-dependent diabetes. Sernova president and CEO Philip Toleikis said:
The proceeds will be used to advance the company’s ongoing spinal muscular atrophy (SMA) clinical program and expand key operational capabilities. The Class D financing was led by
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.